| Latest | F'cast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -42.1% | -34.7% |
| ROCE | n/a |
| Latest | F'cast | |
|---|---|---|
| P/E | n/a | n/a |
| PEG | n/a | n/a |
| Pr/Revenue | 6.7 | 7.2 |
| Pr/Book | 1.6 |
| Latest | F'cast | |
|---|---|---|
| Revenue | -23.1% | -7.3% |
| PBT | n/a | n/a |
| EPS | n/a | n/a |
| DPS | n/a | n/a |
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Mar-08 | 25.20 | (21.40) | (6.10)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Mar-09 | 31.20 | (19.60) | (5.20)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Mar-10 | 40.10 | (13.80) | (3.20)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Mar-11 | 42.90 | (13.30) | (2.70)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Mar-12 | 33.00 | (13.20) | (1.30)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Mar-13 | 30.58 | (10.60) | (1.48)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Mar-14 | 42.44 | 6.10 | 2.49p | 26.6 | n/a | n/a | n/a | 0.0% |
Copyright © 2012 FactSet Research Systems Inc. All rights reserved.
| Awards under share incentive plan | 25-May-2012 | 13:03 | RNS |
| Positive NVA237 Phase III data in COPD Patients | 17-May-2012 | 07:00 | RNS |
| Board appointment | 03-May-2012 | 07:00 | RNS |
| Drug trial success boosts Vectura | 24-Apr-2012 | ShareCast |
| Tuesday broker round-up | 24-Apr-2012 | ShareCast |
| Vectura study reaches end point of third phase o... | 02-Apr-2012 | ShareCast |
| One to watch: Vectura | 13-Jul-2011 | The Scotsman |
| The potential for inhalable drugs to change medi... | 19-Feb-2007 | Times |
| Asthma venture gives Vectura boost | 22-Dec-2006 | The Independent |
No deals were found in the last 28 days.
| Currency | UK Pounds |
| Share Price | 66.25p |
| Change Today | -0.50p |
| % Change | -0.75 % |
| 52 Week High | 104.00p |
| 52 Week Low | 51.00p |
| Volume | 107,026 |
| Shares Issued | 331.73m |
| Market Cap | £219.77m |
| Beta | 0.59 |
| RiskGrade | 246 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| Strong Buy | 7 |
| Buy | 1 |
| Neutral | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 8 |

| No dividends found |
| Time | Volume / Share Price |
| 16:14 | 803 @ 65.25p |
| 16:02 | 3,084 @ 67.25p |
| 15:53 | 2,000 @ 66.23p |
| 15:32 | 177 @ 66.75p |
| 15:25 | 6,706 @ 65.37p |
You are here: research